Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark Geyer
Reduced Toxicity Conditioning With Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children With High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of aGVHD
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Reduced Toxicity, Myeloablative Conditioning With BU, Fludarabine, Alemtuzumab and SCT From Sibling Donors in Children With Sickle Cell Disease
Bone Marrow Transplantation
Transplantation
Hematology
Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children With Sickle Cell Disease
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin
Neoplasma
Cancer Research
Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS
Bone Marrow Transplantation
Transplantation
Hematology
Reduced Intensity Conditioning HLA Identical Sibling Donor Allogeneic Stem Cell Transplantation for Patients With Follicular Lymphoma: Long-Term Follow-Up From Two Prospective Multicenter Trials
Haematologica
Hematology
Reduced Toxicity Conditioning (RTC) and Allogeneic Stem Cell Transplantation (AlloSCT) for Pediatric Sickle Cell Disease (SCD): Significant Improvement in Physical Functioning
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Missing HLA C Group 1 Ligand in Patients With AML and MDS Is Associated With Reduced Risk of Relapse and Better Survival After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning
American Journal of Hematology
Hematology
Choosing a Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine Busulfan Versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
